What controls TOR?

被引：32

作者：

Jacinto, Estela ^{[1
]}

机构：

[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA

来源：

IUBMB LIFE | 2008年 / 60卷 / 08期

关键词：

enzyme mechanisms; eukaryotic gene expression; molecular genetics; phosphoinositides; protein function; protein synthesis; signal transduction;

D O I：

10.1002/iub.56

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The target of rapamycin (TOR) is a protein kinase with numerous functions in cell growth control. Some of these functions can be potently inhibited by rapamycin, an immunosuppressive and potential anticancer drug. TOR exists as part of two functionally distinct protein complexes. The functions of TOR complex 1 (TORC1) are effectively inhibited by rapamycin, but the mechanism for this inhibition remains elusive. The identification of TORC2 and recent reports that rapamycin can inhibit TORC2 functions, in some cases, challenge current models of TOR regulation. This review discusses the latest findings in yeast and mammals on the possible mechanisms that control TOR activity leading to its many cellular functions. (c) 2008 IUBMB.

引用

收藏

页码：483 / 496

页数：14

相关论文

共 143 条

[1] Structure of TOR and its complex with KOG1 [J].

Adami, Alessandra ;

Garcia-Alvarez, Begona ;

Arias-Palomo, Ernesto ;

Barford, David ;

Llorca, Oscar .

MOLECULAR CELL, 2007, 27 (03) :509-516

[2] Rapamycin regulates the phosphorylation of rictor [J].

Akcakanat, Argun ;

Singh, Gopal ;

Hung, Mien-Chie ;

Meric-Bernstam, Funda .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 362 (02) :330-333

[3] Fission yeast Tor2 promotes cell growth and represses cell differentiation [J].

Alvarez, Beatriz ;

Moreno, Sergio .

JOURNAL OF CELL SCIENCE, 2006, 119 (21) :4475-4485

[4] Probing the membrane environment of the TOR kinases reveals functional interactions between TORC1, actin, and membrane trafficking in Saccharomyces cerevisiae [J].

Aronova, Sofia ;

Wedaman, Karen ;

Anderson, Scott ;

Yates, John, III ;

Powers, Ted .

MOLECULAR BIOLOGY OF THE CELL, 2007, 18 (08) :2779-2794

[5] Thinking globally and acting locally with TOR [J].

Arsham, Andrew M. ;

Neufeld, Thomas P. .

CURRENT OPINION IN CELL BIOLOGY, 2006, 18 (06) :589-597

[6] Genome-wide lethality screen identifies new PI4,5P2 effectors that regulate the actin cytoskeleton [J].

Audhya, A ;

Loewith, R ;

Parsons, AB ;

Gao, L ;

Tabuchi, M ;

Zhou, HL ;

Boone, C ;

Hall, MN ;

Emr, SD .

EMBO JOURNAL, 2004, 23 (19) :3747-3757

[7] Modulation of the mammalian target of rapamycin pathway by diacylglycerol kinase-produced phosphatidic acid [J].

Avila-Flores, A ;

Santos, T ;

Rincón, E ;

Mérida, I .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (11) :10091-10099

[8] Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase [J].

Avruch, J. ;

Hara, K. ;

Lin, Y. ;

Liu, M. ;

Long, X. ;

Ortiz-Vega, S. ;

Yonezawa, K. .

ONCOGENE, 2006, 25 (48) :6361-6372

[9] Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38 [J].

Bai, Xiaochun ;

Ma, Dongzhu ;

Liu, Anling ;

Shen, Xiaoyun ;

Wang, Qiming J. ;

Liu, Yongjian ;

Jiang, Yu .

SCIENCE, 2007, 318 (5852) :977-980

[10] Characterization of the FKBP•Rapamycin•FRB ternary complex [J].

Banaszynski, LA ;

Liu, CW ;

Wandless, TJ .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (13) :4715-4721

← 1 2 3 4 5 6 7 8 9 10 →